Clinical Cancer Research Meeting Calendar Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Im, S. S.
Right arrow Articles by Monk, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Im, S. S.
Right arrow Articles by Monk, B. J.
Clinical Cancer Research Vol. 9, 4145-4150, September 15, 2003
© 2003 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Early Stage Cervical Cancers Containing Human Papillomavirus Type 18 DNA Have More Nodal Metastasis and Deeper Stromal Invasion1

Samuel S. Im, Sharon P. Wilczynski, Robert A. Burger and Bradley J. Monk2

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Chao Family Comprehensive Cancer Center, University of California, Irvine Medical Center, Orange, California 92868 [S. S. I., R. A. B., B. J. M.], and Department of Anatomic Pathology, City of Hope National Medical Center, Duarte, California 91010 [S. P. W.]

Purpose: To investigate the clinical and pathological factors which might explain the poor prognosis associated with early stage cervical cancers containing human papillomavirus (HPV) type 18 DNA.

Experimental Design: A clinical and pathological review of 144 patients with stage IB cervical cancer treated with radical hysterectomy and bilateral pelvic lymph node dissection was done. HPV genotyping was determined from fresh tumor specimens through PCR. Clinical-pathological information, sites of recurrence, use of adjuvant radiation, and survival data were analyzed.

Results: Thirty-three (23%) tumors contained HPV 18 DNA. These tumors did not differ from those which contained non-HPV 18 DNA with respect to tumor grade or size. However, HPV 18-containing cancers were more likely to be adenocarcinomas. A higher incidence of pelvic lymph node metastasis was noted among the HPV 18 group (48%) as compared with the non-HPV 18 group (28%), and deeper stromal invasion was more common in HPV 18-associated tumors. Although a slightly higher proportion of patients with HPV 18-containing tumors received adjuvant radiation (67%) than those with non-HPV 18 cancers (49%), recurrences were more common among HPV 18 patients. Eleven (33%) of HPV 18-containing cancers relapsed compared with 18 (16%) of non-HPV18-containing tumors.

Conclusions: The explanation for the worse prognosis associated with stage IB cervical cancers containing HPV 18 DNA treated with radical hysterectomy and bilateral pelvic lymph node dissection appears to be related to deeper cervical stromal invasion and more nodal metastases. Despite an increased use of adjuvant radiation therapy, these cancers are still more likely to relapse.




This article has been cited by other articles:


Home page
J. Virol.Home page
Y.-H. Tsai, M.-F. Wu, Y.-H. Wu, S.-J. Chang, S.-F. Lin, T. V. Sharp, and H.-W. Wang
The M Type K15 Protein of Kaposi's Sarcoma-Associated Herpesvirus Regulates MicroRNA Expression via Its SH2-Binding Motif To Induce Cell Migration and Invasion
J. Virol., January 15, 2009; 83(2): 622 - 632.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Vinokurova, N. Wentzensen, I. Kraus, R. Klaes, C. Driesch, P. Melsheimer, F. Kisseljov, M. Durst, A. Schneider, and M. von Knebel Doeberitz
Type-Dependent Integration Frequency of Human Papillomavirus Genomes in Cervical Lesions
Cancer Res., January 1, 2008; 68(1): 307 - 313.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Seresini, M. Origoni, F. Lillo, L. Caputo, A. M. Paganoni, S. Vantini, R. Longhi, G. Taccagni, A. Ferrari, C. Doglioni, et al.
IFN-{gamma} Produced by Human Papilloma Virus-18 E6-Specific CD4+ T Cells Predicts the Clinical Outcome after Surgery in Patients with High-Grade Cervical Lesions
J. Immunol., November 15, 2007; 179(10): 7176 - 7183.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C.-H. Lai, C.-J. Chang, H.-J. Huang, S. Hsueh, A. Chao, J.-E. Yang, C.-T. Lin, S.-L. Huang, J.-H. Hong, H.-H. Chou, et al.
Role of Human Papillomavirus Genotype in Prognosis of Early-Stage Cervical Cancer Undergoing Primary Surgery
J. Clin. Oncol., August 20, 2007; 25(24): 3628 - 3634.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
E. De la Cruz-Hernandez, A. Garcia-Carranca, A. Mohar-Betancourt, A. Duenas-Gonzalez, A. Contreras-Paredes, E. Perez-Cardenas, R. Herrera-Goepfert, and M. Lizano-Soberon
Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences
J. Gen. Virol., September 1, 2005; 86(9): 2459 - 2468.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.